UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer

Clinical cancer research, 2017-09, Vol.23 (18), p.5489-5501

2017

Volltextzugriff (PDF)

Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells

Clinical cancer research, 2005-10, Vol.11 (19), p.6924-6932

2005

Volltextzugriff (PDF)

Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1958-1965

2009

Volltextzugriff (PDF)

Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer

Clinical cancer research, 2009-11, Vol.15 (22), p.6852-6861

2009

Volltextzugriff (PDF)

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines

The American journal of pathology, 2007, Vol.170 (1), p.366-376

2007

Volltextzugriff (PDF)

8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition

PloS one, 2015-08, Vol.10 (8), p.e0135962-e0135962

2015

Volltextzugriff (PDF)

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion

Molecular cancer therapeutics, 2007-07, Vol.6 (7), p.1962-1972

2007

Volltextzugriff (PDF)

Abrogation of Signal Transducer and Activator of Transcription 3 Reactivation after Src Kinase Inhibition Results in Synergistic Antitumor Effects

Clinical cancer research, 2007-07, Vol.13 (14), p.4233-4244

2007

Volltextzugriff (PDF)

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

Cancer medicine (Malden, MA), 2020-02, Vol.9 (3), p.1025-1032

2020

Volltextzugriff (PDF)

EphA2 in the early pathogenesis and progression of non-small cell lung cancer

Cancer prevention research (Philadelphia, Pa.), 2009-12, Vol.2 (12), p.1039-1049

2009

Volltextzugriff (PDF)

Prevention of Stomatitis: Using Dexamethasone-Based Mouthwash to Inhibit Everolimus-Related Stomatitis

Clinical journal of oncology nursing, 2018-04, Vol.22 (2), p.211-217

2018

Volltextzugriff (PDF)

Abstract OT-34-01: Phase Ib/II trial of copanlisib in combination with trastuzumab and pertuzumab after induction treatment of HER2 positive metastatic breast cancer with PIK3CA mutation or PTEN mutation

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-34-01-OT-34-01

2021

Volltextzugriff (PDF)

KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling

The Journal of clinical investigation, 2013-12, Vol.123 (12), p.5231-5246

2013

Volltextzugriff (PDF)

Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLC

Journal of thoracic oncology, 2021-12, Vol.16 (12), p.2051-2064

2021

Volltextzugriff (PDF)

Estrogen promotes resistance to bevacizumab in murine models of non-small cell lung cancer

Journal of thoracic oncology, 2021-07, Vol.16 (12), p.2051-2064

2021

Volltextzugriff (PDF)

Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck Cancer

Clinical cancer research, 2011-02, Vol.17 (3), p.514-524

2011

Volltextzugriff (PDF)

Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer

Journal of the National Comprehensive Cancer Network, 2018-05, Vol.16 (5), p.518-524

2018

Volltextzugriff (PDF)

Phase II study of Ra-223 combined with hormonal therapy and denosumab for treatment of hormone receptor-positive breast cancer with bone-dominant metastasis

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1065-1065

2018

Volltextzugriff (PDF)

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer

Oncotarget, 2018-03, Vol.9 (18), p.14268-14284

2018

Volltextzugriff (PDF)

Referral for genetic counseling in survivors of triple negative breast cancer (TNBC): An ongoing objective

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1095-1095

2016

Volltextzugriff (PDF)

A phase 1 trial of vandetanib (multikinase inhibitor of EGFR, VEGFR, and RET) in combination with everolimus (mTOR inhibitor) in patients with advanced malignancies

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS2639-TPS2639

2014

Volltextzugriff (PDF)

Abstract 1046: Differential interactions between c-Src and c-Met mediate resistance to c-Src inhibitors

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1046-1046

2011

Volltextzugriff (PDF)

Abstract 3273: Estrogen contributes to bevacizumab resistance in xenograft models of non-small cell lung cancer (NSCLC)

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3273-3273

2011

Volltextzugriff (PDF)

Degradation of phagosomal components in late endocytic organelles

Journal of cell science, 1998-01, Vol.111 ( Pt 1) (1), p.141-148

1998

Volltextzugriff (PDF)

Abstract 5146: The histone demethylase KDM2A is a new promoter of tumorigenesis, drug target and negative prognostic biomarker for non-small cell lung cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5146-5146

2014

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(17)
Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Oncology
(13)
Cell Line, Tumor
(11)
Animals
(7)
Female
(7)
Mice
(7)
Tumors
(7)
Dasatinib
(6)
Pyrimidines - Pharmacology
(6)
Apoptosis - Drug Effects
(5)
Biological And Medical Sciences
(5)
Blotting, Western
(5)
Lung Cancer
(5)
Male
(5)
Medical Sciences
(5)
Phosphorylation
(5)
Protein Kinase Inhibitors - Pharmacology
(5)
Thiazoles - Pharmacology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer

Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells

Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding

Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines

8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion

Abrogation of Signal Transducer and Activator of Transcription 3 Reactivation after Src Kinase Inhibition Results in Synergistic Antitumor Effects

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

EphA2 in the early pathogenesis and progression of non-small cell lung cancer

Prevention of Stomatitis: Using Dexamethasone-Based Mouthwash to Inhibit Everolimus-Related Stomatitis

Abstract OT-34-01: Phase Ib/II trial of copanlisib in combination with trastuzumab and pertuzumab after induction treatment of HER2 positive metastatic breast cancer with PIK3CA mutation or PTEN mutation

KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling

Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLC

Estrogen promotes resistance to bevacizumab in murine models of non-small cell lung cancer

Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck Cancer

Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer

Phase II study of Ra-223 combined with hormonal therapy and denosumab for treatment of hormone receptor-positive breast cancer with bone-dominant metastasis

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer

Referral for genetic counseling in survivors of triple negative breast cancer (TNBC): An ongoing objective

A phase 1 trial of vandetanib (multikinase inhibitor of EGFR, VEGFR, and RET) in combination with everolimus (mTOR inhibitor) in patients with advanced malignancies

Abstract 1046: Differential interactions between c-Src and c-Met mediate resistance to c-Src inhibitors

Abstract 3273: Estrogen contributes to bevacizumab resistance in xenograft models of non-small cell lung cancer (NSCLC)

Degradation of phagosomal components in late endocytic organelles

Abstract 5146: The histone demethylase KDM2A is a new promoter of tumorigenesis, drug target and negative prognostic biomarker for non-small cell lung cancer

Suchergebnisse filtern